CHENGDU, China, Sept. 29 /PRNewswire-Asia-FirstCall/ -- Tianyin
Pharmaceutical Co., Inc., (NYSE Amex: TPI), a biopharmaceutical company that
specializes in patented biopharmaceutical, modernized traditional Chinese
medicine ("TCM"), branded generics and other pharmaceuticals, announced the
resul